Skip to main content
. Author manuscript; available in PMC: 2008 Oct 1.
Published in final edited form as: Arch Gen Psychiatry. 2007 Oct;64(10):1180–1188. doi: 10.1001/archpsyc.64.10.1180

Table 3.

Prevalence and Associations of Chronic Physical and Mental Conditions With Role Disability at the Population Level (Simulated Net Coefficientsa)

  12-Month Prevalence, b % (SE) US Days per Year in Millions, c No. (SE)
Physical conditions    
   Cancer 1.0 (0.2) 71.5 (33.7)
   Cardiovascular    
     Heart attack 3.7 (0.4) 204.0 (81.3)
     Stroke 2.7 (0.3) 220.8 (59.6)
     All cardiovascular 5.8 (0.4) 424.8 (85.4)
   Chronic obstructive pulmonary disease 2.2 (0.3) 176.3 (47.1)
   Digestive    
     Irritable bowel syndrome 0.9 (0.2) 104.3 (45.9)
     Ulcer 2.4 (0.2) 112.7 (39.9)
     All digestive 3.3 (0.2) 217.0 (55.8)
   Musculoskeletal    
     Back/neck pain 19.0 (0.8) 1167.8 (159.2)
     Arthritis 27.3 (0.9) 374.6 (150.5)
     All musculoskeletal 36.6 (1.1) 1167.8 (153.9)
   Sense organs    
     Hearing impairment 3.8 (0.3) 188.8 (56.2)
     Vision impairment 3.2 (0.3) 144.0 (48.8)
     All sense organs 6.3 (0.4) 393.2 (126.6)
   All physical 42.9 (1.1) 2378.3 (172.2)
Mental conditions    
   Anxiety disorders    
     Agoraphobia 0.8 (0.1) 37.1 (8.7)
     Generalized anxiety disorder 3.1 (0.2) 109.5 (13.8)
     Panic disorder 2.8 (0.2) 101.2 (16.0)
     Posttraumatic stress disorder 3.5 (0.3) 112.5 (22.9)
     Separation anxiety disorder 0.6 (0.1) 19.5 (6.5)
     Social phobia 6.9 (0.3) 213.8 (28.7)
     Specific phobia 8.8 (0.4) 253.3 (37.8)
     All anxiety 18.0 (0.7) 706.6 (119.9)
   Mood disorders    
     Major depressive disorder 6.7 (0.3) 386.6 (58.0)
     Bipolar I (mania) 2.1 (0.2) 103.1 (32.5)
     All mood 8.8 (0.4) 489.7 (71.5)
   Substance dependence    
     Alcohol dependence 1.3 (0.2) 69.9 (24.3)
     Drug dependence 0.4 (0.1) 13.1 (4.9)
     All substance 1.6 (0.2) 96.0 (33.0)
   All mental or substance 22.3 (0.7) 1292.2 (154.2)
Any disorder 53.4 (1.0) 3588.0 (193.0)
Total sample 5692  
a

Prevalence estimates focus on disorders with significant coefficients in the simulated net effects model.

b

All coefficients are significant at the .05 level, using 2-sided tests.

c

Estimates are controlled for age, sex, race/ethnicity, education, and the cross-classification of marital status, employment status, and the number and ages of children.